Apollo Medical Holdings, Inc. (AMEH)
(Delayed Data from NSDQ)
$19.93 USD
+0.41 (2.10%)
Updated May 3, 2019 04:00 PM ET
After-Market: $19.92 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$19.93 USD
+0.41 (2.10%)
Updated May 3, 2019 04:00 PM ET
After-Market: $19.92 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Hologic (HOLX) COVID Test With Saliva Sample Gets CE Mark
by Zacks Equity Research
Per Hologic (HOLX), saliva collection is noninvasive and painless. The availability of this alternative specimen type should facilitate screening at schools, workplaces and other settings.
Orthofix's (OFIX) SpinalStim Demonstrates Improved Fusion Rates
by Zacks Equity Research
Orthofix's (OFIX) SpinalStim bone growth device demonstrates impressive fusion rates for patients recovering from lumbar fusion surgery.
Amedisys (AMED) Latest New York Assets Buyout Aids Home Health
by Zacks Equity Research
The latest development remains in line with Amedisys' (AMED) ongoing efforts to expand footprint in key markets.
Charles River (CRL) at a 52-Week High: What's Driving It?
by Zacks Equity Research
Strong performance by the RMS, DSA and Manufacturing segments is driving the top line for Charles River (CRL).
LHC Group (LHCG) & SCP Health to Offer Home Health Services
by Zacks Equity Research
LHC Group (LHCG) collaborates with SCP Health to provide innovative and advanced in-home healthcare services.
Zacks.com featured highlights include: Apollo Medical, Atento, Grindrod Shipping, Nike and NVIDIA
by Zacks Equity Research
Zacks.com featured highlights include: Apollo Medical, Atento, Grindrod Shipping, Nike and NVIDIA
5 Stocks With Recent Price Strength Following a Strong 1H
by Nalak Das
Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength like NKE, GRIN, NVDA, AMEH and ATTO have a high chance of carrying the momentum forward.
The Zacks Analyst Blog Highlights: Chico's FAS, Build-A-Bear, 3D Systems and Apollo Medical
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Chico's FAS, Build-A-Bear, 3D Systems and Apollo Medical
Walgreens Boots (WBA) Q3 Earnings Top Estimates, 2021 View Up
by Zacks Equity Research
Walgreens Boots (WBA) revenues improve 12.1% year-over-year in the third quarter on robust growth in the International and United States segments.
4 Top-Performing Stocks of a Strong H1 With More Room to Run
by Tirthankar Chakraborty
Chico's FAS (CHS), Build-A-Bear Workshop (BBW), 3D Systems (DDD) & Apollo Medical (AMEH) not only gained immensely in the first half but are also likely to continue gains in the near term.
HealthEquity (HQY) Q1 Earnings Beat Estimates, FY22 View Up
by Zacks Equity Research
HealthEquity (HQY) delivers solid growth in HSAs along with recording robust Interchange revenues in the first quarter of fiscal 2022.
Intersect ENT (XENT) Receives CE Mark for PROPEL Contour
by Zacks Equity Research
The CE Mark approval is backed by positive results from Intersect ENT's (XENT) PROGRESS clinical study of the PROPEL Contour.
QIAGEN (QGEN) Gains from FDA's EUA for Antibody Total Test
by Zacks Equity Research
QIAGEN's (QGEN) COVID-19 total antibody test processes up to 32 swab samples per hour.
Zacks Industry Outlook Highlights: Avantor, Eurofins Scientific, GoodRx Holdings, Apollo Medical and COMPASS Pathways
by Zacks Equity Research
Zacks Industry Outlook Highlights: Avantor, Eurofins Scientific, GoodRx Holdings, Apollo Medical and COMPASS Pathways
5 Top Medical Services Stocks to Beat COVID-Led Industry Challenges
by Urmimala Biswas
Despite the severe challenges posed by the COVID-19 pandemic, higher demand for telemedicine, digital influence and AI is likely to lend support to the Zacks Medical - Services industry. AVTR, ERFSF, GDRX, AMEH and CMPS are poised to gain.
Apollo Medical Holdings, Inc. (AMEH) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Apollo Medical Holdings, Inc. (AMEH) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks Industry Outlook Highlights: MedTech, including Natus Medical, Owens & Minor, Penumbra, Apollo Medical and ENDRA Life Sciences
by Zacks Equity Research
Zacks Industry Outlook Highlights: MedTech, including Natus Medical, Owens & Minor, Penumbra, Apollo Medical and ENDRA Life Sciences
5 MedTech Outperformers With Nearly 40% or More Gain in 2021
by Debanjana Dey
Here are a few MedTech stocks, Natus Medical (NTUS), Owens & Minor (OMI), ENDRA Life Sciences (NDRA), Penumbra (PEN), Apollo Medical (AMEH), which might be prudent investment choices now.
Is Apollo Medical Holdings, Inc. (AMEH) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
What Makes Apollo Medical Holdings, Inc. (AMEH) a New Buy Stock
by Zacks Equity Research
Apollo Medical Holdings, Inc. (AMEH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Apollo Medical Holdings, Inc. (AMEH) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Apollo Medical Holdings, Inc. (AMEH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
5 Little-Known Stocks Under $20 Analysts Recommend Buying
by Anindya Barman
We recommend a few lesser-known stocks that hold promise for high returns this year. ADTN, AMEH, ATEC, DFIN and DGII fit the bill.
Zacks Industry Outlook Highlights: Apollo Medical, bioMerieux, CareDx and Harrow Health
by Zacks Equity Research
Zacks Industry Outlook Highlights: Apollo Medical, bioMerieux, CareDx and Harrow Health
4 Top Medical Services Stocks to Beat COVID-19 Resurgence Crisis
by Urmimala Biswas
Despite the severe challenges posed by the COVID-19 pandemic, higher demand for telemedicine, digital influence and AI is likely to lend support to the Zacks Medical - Service industry. AMEH, BMXMF, CDNA and HROW are well positioned to gain.
Harrow Health (HROW) Looks Good: Stock Adds 9.1% in Session
by Zacks Equity Research
Harrow Health (HROW) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.